Stocks
Applied Therapeutics (APLT) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 1.00 | 0.75 | 0.35 | 0.76 | 0.73 | 0.09 | |||
| Changes by years, y/y, % | +23% | -25% | -53% | +118% | -4% | -1.9% | |||
Applied Therapeutics. Debt/EBITDA
Applied Therapeutics. Debt/EBITDA, changes, %
Applied Therapeutics (APLT) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | LTM ? | |||
| Debt/EBITDA | 1.05 | 0.71 | 0.44 | 0.25 | 0.09 | 0.09 | ||
| Changes by years, y/y, % | +81% | -8% | -77% | -84% | -91% | |||
| Changes by quarters, q/q, % | -33% | -33% | -37% | -44% | -62% | |||
